Clinical trial

HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)

NCT03783065

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-01-02

PhaseNA

Study timeline

Study start (actual)2019-01-02Date precision: day

Registry last updated2021-08-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Portal Hypertensionunresolved

Variceal Rebleedingunresolved

Interventions

PropranololDRUG · verified · RxNorm: propranolol

Laparoscopic splenectomy and pericardial devascularizationPROCEDURE

Endoscopic therapyPROCEDURE

Sponsors & collaborators

Nanfang Hospital, Southern Medical Universitylead sponsor

Southern Medical University, Chinacollaborator

Xingtai People's Hospitalcollaborator

Beijing 302 Hospitalcollaborator

LanZhou Universitycollaborator

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03783065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.